Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center">Linearity range</td><td align="center">Correlation coefficient</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Montelukast</td><td align="center">0.005–0.015 mg/mL</td><td align="center">0.9941</td></tr><tr><td align="left">Doxofylline</td><td align="center">0.2–0.6 mg/mL</td><td align="center">0.9935</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Chemistry

tab2

Table 2

Table 2: Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms 

Table 2 | Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms 